Elevated cholesterol metabolism and bile acid synthesis in mice lacking membrane tyrosine kinase receptor FGFR4

被引:298
作者
Yu, CD
Wang, F
Kan, M
Jin, CL
Jones, RB
Weinstein, M
Deng, CX
McKeehan, WL
机构
[1] Texas A&M Univ, Inst Biosci & Technol, Syst Hlth Sci Ctr, Ctr Canc Biol & Nutr, Houston, TX 77030 USA
[2] Texas A&M Univ, Dept Biochem & Biophys, Houston, TX 77030 USA
[3] Univ Texas, Hlth Sci Ctr, Grad Sch Biomed Sci, Houston, TX 77030 USA
[4] NIDDK, Genet Dev & Dis Branch, NIH, Bethesda, MD 20892 USA
关键词
D O I
10.1074/jbc.275.20.15482
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Heparan sulfate-regulated transmembrane tyrosine kinase receptor FGFR4 is the major FGFR isotype in mature hepatocytes. Fibroblast growth factor has been implicated in the definition of liver from foregut endoderm where FGFR4 is expressed and stimulation of hepatocyte DNA synthesis in vitro, Here we show that livers of mice lacking FGFR4 exhibited normal morphology and regenerated normally in response to partial hepatectomy, However, the FGFR4 (-/-) mice exhibited depleted gallbladders, an elevated bile acid pool and elevated excretion of bile acids. Cholesterol- and bile acid-controlled liver cholesterol 7 alpha-hydroxylase, the limiting enzyme for bile acid synthesis, was elevated, unresponsive to dietary cholesterol, but repressed normally by dietary cholate, Expression pattern and cholate-dependent, cholesterol-induced hepatomegaly in the FGFR4 (-/-) mice suggested that activation of receptor interacting protein 140, a co-repressor of feed-forward activator liver X receptor alpha, may mediate the negative regulation of cholesterol- and bile acid-controlled liver cholesterol 7 alpha-hydroxylase transcription by FCFR4 and cholate, The results demonstrate that transmembrane sensors interface with metabolite-controlled transcription networks and suggest that pericellular matrix-controlled liver FGFR4 in particular may ensure adequate cholesterol for cell structures and signal transduction.
引用
收藏
页码:15482 / 15489
页数:8
相关论文
共 50 条
[1]  
BJORKHEM I, 1992, J LIPID RES, V33, P455
[2]  
BROWN MS, 1980, J LIPID RES, V21, P505
[3]  
Chiang John Y. L., 1998, Frontiers in Bioscience, V3, pD176
[4]   Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3 [J].
Colvin, JS ;
Bohne, BA ;
Harding, GW ;
McEwen, DG ;
Ornitz, DM .
NATURE GENETICS, 1996, 12 (04) :390-397
[5]   MURINE FGFR-1 IS REQUIRED FOR EARLY POSTIMPLANTATION GROWTH AND AXIAL ORGANIZATION [J].
DENG, CX ;
WYNSHAWBORIS, A ;
SHEN, MM ;
DAUGHERTY, C ;
ORNITZ, DM ;
LEDER, P .
GENES & DEVELOPMENT, 1994, 8 (24) :3045-3057
[6]   Fibroblast growth factor receptor 3 is a negative regulator of bone growth [J].
Deng, CX ;
WynshawBoris, A ;
Zhou, F ;
Kuo, A ;
Leder, P .
CELL, 1996, 84 (06) :911-921
[7]  
Feingold KR, 1996, J LIPID RES, V37, P223
[8]   REGULATION OF THE MEVALONATE PATHWAY [J].
GOLDSTEIN, JL ;
BROWN, MS .
NATURE, 1990, 343 (6257) :425-430
[9]   Role of cholesterol in formation and function of a signaling complex involving αvβ3, integrin-associated protein (CD47), and heterotrimeric G proteins [J].
Green, JM ;
Zhelesnyak, A ;
Chung, J ;
Lindberg, FP ;
Sarfati, M ;
Frazier, WA ;
Brown, EJ .
JOURNAL OF CELL BIOLOGY, 1999, 146 (03) :673-682
[10]   Estrogen regulation of the apolipoprotein AI gene promoter through transcription cofactor sharing [J].
Harnish, DC ;
Evans, MJ ;
Scicchitano, MS ;
Bhat, RA ;
Karathanasis, SK .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (15) :9270-9278